These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 8282330)
1. Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans. Fisher ND; Allan D; Kifor I; Gaboury CL; Williams GH; Moore TJ; Hollenberg NK Hypertension; 1994 Jan; 23(1):44-51. PubMed ID: 8282330 [TBL] [Abstract][Full Text] [Related]
2. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363 [TBL] [Abstract][Full Text] [Related]
3. Renal response to captopril reflects state of local renin system in healthy humans. Fisher ND; Price DA; Litchfield WR; Williams GH; Hollenberg NK Kidney Int; 1999 Aug; 56(2):635-41. PubMed ID: 10432403 [TBL] [Abstract][Full Text] [Related]
4. Captopril enhances vascular and adrenal responsiveness to angiotensin II in essential hypertension. Koletsky RJ; Gordon MB; LeBoff MS; Moore TJ; Dluhy RG; Hollenberg NK; Williams GH Clin Sci (Lond); 1984 Mar; 66(3):299-305. PubMed ID: 6362960 [TBL] [Abstract][Full Text] [Related]
5. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition. De'Oliveira JM; Price DA; Fisher ND; Allan DR; McKnight JA; Williams GH; Hollenberg NK Kidney Int; 1997 Sep; 52(3):771-7. PubMed ID: 9291199 [TBL] [Abstract][Full Text] [Related]
6. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696 [TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans. Osei SY; Price DA; Fisher ND; Porter L; Laffel LM; Hollenberg NK Hypertension; 1999 Jan; 33(1 Pt 2):559-64. PubMed ID: 9931165 [TBL] [Abstract][Full Text] [Related]
8. Intrarenal angiotensin II formation in humans. Evidence from renin inhibition. Fisher ND; Allan DR; Gaboury CL; Hollenberg NK Hypertension; 1995 May; 25(5):935-9. PubMed ID: 7737730 [TBL] [Abstract][Full Text] [Related]
9. Renal and endocrine responses to a renin inhibitor, enalkiren, in normal humans. Cordero P; Fisher ND; Moore TJ; Gleason R; Williams GH; Hollenberg NK Hypertension; 1991 Apr; 17(4):510-6. PubMed ID: 2013477 [TBL] [Abstract][Full Text] [Related]
10. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives. Redgrave J; Rabinowe S; Hollenberg NK; Williams GH J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655 [TBL] [Abstract][Full Text] [Related]
11. Role of the tissue renin-angiotensin system in the action of angiotensin-converting enzyme inhibitors. Tokita Y; Oda H; Franco-Saenz R; Mulrow PJ Proc Soc Exp Biol Med; 1995 Apr; 208(4):391-6. PubMed ID: 7700888 [TBL] [Abstract][Full Text] [Related]
12. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition. Guidi E; Hollenberg NK J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668 [TBL] [Abstract][Full Text] [Related]
13. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension. Azizi M; Guyene TT; Chatellier G; Ménard J J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166 [TBL] [Abstract][Full Text] [Related]
14. Preservation of renal function by angiotensin during chronic adrenergic stimulation. Lohmeier TE; Yang HM Hypertension; 1991 Mar; 17(3):278-87. PubMed ID: 1999358 [TBL] [Abstract][Full Text] [Related]
15. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension. van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular regulation during angiotensin converting enzyme inhibition with captopril in diabetes-associated hypertension. Beretta-Piccoli C; Ziegler WH; Antonini P; Bernasconi-Zapf M; Kressebuch H; Pianezzi F J Hypertens; 1990 Jul; 8(7):671-8. PubMed ID: 2168458 [TBL] [Abstract][Full Text] [Related]
17. Differential pressor and renal vascular reactivity to angiotensin II in spontaneously hypertensive and Wistar-Kyoto rats. Guidi E; Hollenberg NK Hypertension; 1987 Jun; 9(6):591-7. PubMed ID: 3294592 [TBL] [Abstract][Full Text] [Related]
18. Renal perfusion and function in healthy African Americans. Price DA; Fisher ND; Osei SY; Lansang MC; Hollenberg NK Kidney Int; 2001 Mar; 59(3):1037-43. PubMed ID: 11231358 [TBL] [Abstract][Full Text] [Related]
19. Influence of angiotensin II on pressure natriuresis and renal hemodynamics in volume-expanded rats. Mattson DL; Raff H; Roman RJ Am J Physiol; 1991 Jun; 260(6 Pt 2):R1200-9. PubMed ID: 2058747 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin II blunts, while an angiotensin-converting enzyme inhibitor augments, reflex sympathetic inhibition in humans. Miyajima E; Shigemasa T; Yamada Y; Tochikubo O; Ishii M Clin Exp Pharmacol Physiol; 1999 Oct; 26(10):797-802. PubMed ID: 10549404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]